Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.

Several companies have produced biosimilar versions of Humira. Fujifilm Kyowa Kirin Biologics granted Mylan an exclusive licence to commercialise its version of adalimumab, Hulio, in Europe.